Written and maintained by CASRAI Editorial Board
Last updated
Telepsychiatry is a specialized clinical subdiscipline of telemedicine that delivers psychiatric evaluation, diagnostic assessment, psychopharmacological management, psychotherapy, and consultative behavioral health care across geographic distances using telecommunications technology. In clinical practice and academic health systems, telepsychiatry most commonly utilizes real-time, two-way interactive audio-video conferencing, supplemented by asynchronous store-and-forward consultations and remote physiological or behavioral monitoring. Governed jointly by guidelines from the American Psychiatric Association (APA) and the American Telemedicine Association (ATA) (Best Practices in Videoconferencing-Based Telemental Health), modern telepsychiatry programs operate under strict federal and state regulatory frameworks covering interstate medical licensure, controlled substance prescribing, and behavioral health data segmentation.
What Is Telepsychiatry? Core Clinical Delivery Models
Health systems, community mental health centers (CMHCs), and academic psychiatry departments deploy telepsychiatry across three primary care delivery architectures depending on patient acuity and clinical setting:
- Direct-to-Patient Outpatient Telepsychiatry: Psychiatrists and psychiatric-mental health nurse practitioners (PMHNPs) conduct initial diagnostic evaluations, ongoing medication management, and individual or group psychotherapy with patients located in their homes (`Place of Service [POS] 10`) or originating clinical sites (`POS 02`). Standardized pre-visit workflows—such as a structured intake form for mental health incorporating PHQ-9, GAD-7, and Columbia-Suicide Severity Rating Scale (C-SSRS) instruments—ensure baseline symptom severity and safety risks are captured before the video encounter begins.
- Emergency Department (ED) and Inpatient Consultative-Liaison Telepsychiatry: Acute-care hospitals without 24/7 on-site psychiatric coverage use synchronous telepsychiatry to evaluate patients presenting in acute behavioral crisis, acute psychosis, or severe substance withdrawal. Remote psychiatrists collaborate with on-site ED physicians to perform involuntary commitment safety assessments, initiate acute agitation pharmacotherapy, and reduce psychiatric boarding times in emergency rooms.
- Collaborative Care Model (CoCM) and Integrated Primary Care: Based on the University of Washington AIMS Center IMPACT trial architecture, telepsychiatrists serve as remote psychiatric consultants to primary care providers (PCPs) and embedded behavioral health care managers. Rather than seeing every patient directly via video, the telepsychiatrist conducts systematic weekly caseload reviews using a shared clinical registry (billed under CPT codes
99492,99493, and99494) and provides targeted diagnostic and psychotropic titration recommendations to the PCP, supplemented by asynchronous eConsults (CPT99451).
Emergency Safety Protocols and Remote Mental Status Examination (MSE)
Unlike general medical telemedicine, telepsychiatry requires specialized clinical protocols to manage acute psychiatric decompensation, suicidal ideation, and neurological assessment over video:
- Mandatory Pre-Session Physical Location and Emergency Contact Verification: Under APA/ATA telemental health guidelines, clinicians must verify and document the patient’s exact physical street address at the start of every remote encounter, alongside an emergency support contact. Because dialing 911 from a clinician’s office routes to the clinician’s local dispatch rather than the patient’s jurisdiction, telepsychiatry workflows require rapid lookup access to the patient’s local Public Safety Answering Point (PSAP) and local 988 Suicide & Crisis Lifeline mobile crisis response teams to initiate welfare checks or involuntary emergency detention if a patient expresses imminent self-harm and disconnects.
- Conducting a Video-Adapted Mental Status Examination (MSE): While appearance, speech latency, mood, affect, thought process, thought content, insight, and judgment translate directly to high-definition video, clinicians must adapt motor and neurological components. Evaluating extrapyramidal symptoms (EPS), antipsychotic-induced parkinsonism, akathisia, or tardive dyskinesia requires instructing the patient to adjust camera framing to show their hands resting on their knees, perform rapid alternating movements, and walk across the room to assess gait and posture using structured mental health SOAP note documentation.
DEA Controlled Substance Prescribing and the Ryan Haight Act
Prescribing psychotropic medications via telepsychiatry requires strict differentiation between non-controlled psychiatric medications (such as SSRIs, SNRIs, atypical antipsychotics, mood stabilizers, and non-stimulant ADHD therapies like atomoxetine or viloxazine) and DEA Schedule II–V controlled substances:
- The Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. § 829(e)): Enacted in 2008, the Ryan Haight Act generally requires a DEA-registered practitioner to conduct at least one in-person medical evaluation of a patient prior to issuing a prescription for a controlled substance over the internet, unless a specific statutory exception applies.
- DEA and HHS Telemedicine Flexibilities Extension: During the COVID-19 public health emergency, the Drug Enforcement Administration (DEA) authorized DEA-registered practitioners to prescribe Schedule II–V controlled substances—including Schedule II central nervous system stimulants for ADHD (amphetamine, methylphenidate), Schedule III buprenorphine for opioid use disorder (OUD), and Schedule IV benzodiazepines—via real-time audio-video telemedicine (and audio-only for buprenorphine) without a prior in-person examination. Under the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (jointly issued by the DEA and HHS, 89 FR 91253), these telemedicine prescribing flexibilities remain in full effect through December 31, 2026 while permanent Special Registration for Telemedicine regulations are finalized.
- State PDMP and EPCS Compliance: Even when federal DEA telemedicine flexibilities permit remote prescribing, clinicians must hold active DEA registration and state controlled-substance authority in the state where the patient is physically located at the time of the encounter, query the state Prescription Drug Monitoring Program (PDMP) prior to prescribing, and transmit prescriptions via DEA-compliant Electronic Prescribing for Controlled Substances (EPCS) with two-factor authentication.
Telepsychiatry Platform Architecture, HIPAA, and 42 CFR Part 2
Selecting and configuring a clinical telepsychiatry platform requires technical safeguards that go beyond basic video conferencing:
- HIPAA Security Rule and Business Associate Agreements (BAAs): Video platforms—ranging from specialized healthcare WebRTC applications such as the Doxy.me application and Zoom for Healthcare to EHR-embedded telehealth modules—must operate under an executed HIPAA Business Associate Agreement, utilizing TLS 1.2+/1.3 transport encryption and AES-256 encryption with zero persistent recording of clinical video streams.
- HIPAA Psychotherapy Notes Segmentation (45 CFR § 164.508(a)(2)): If a psychiatrist or psychotherapist records separate psychotherapy process notes analyzing the contents of a counseling conversation, the EHR must store those notes physically or logically segregated from the general medical record (which holds medication logs, diagnostic codes, and SOAP progress summaries), requiring specific patient authorization for disclosure.
- 42 CFR Part 2 Substance Use Disorder (SUD) Confidentiality: Telepsychiatry programs treating co-occurring substance use disorders that qualify as federally assisted Part 2 programs must comply with the 2024 HHS 42 CFR Part 2 Final Rule (89 FR 12472), which aligns Part 2 patient consent for treatment, payment, and healthcare operations (TPO) more closely with HIPAA while maintaining strict prohibitions against using SUD records in civil, criminal, administrative, or legislative proceedings against the patient without a specific court order.
- Ambient AI Documentation Integration: Many telepsychiatry practices pair video visits with a psychiatry-specific AI medical scribe to automatically structure complex psychiatric histories, DSM-5-TR/ICD-10-CM diagnostic formulations, and MSE findings directly from the telehealth audio stream.
Telepsychiatry CPT Coding, Place of Service, and Modifiers
Accurate psychiatric claims submission depends on pairing evaluation and psychotherapy CPT codes with the correct telehealth Place of Service (POS) and synchronous modifiers:
| CPT Code(s) | Clinical Service Description | Telehealth POS & Modifier Rules |
|---|---|---|
| 90791 / 90792 | Psychiatric diagnostic evaluation without medical services (90791) or with medical services / prescribing assessment (90792). |
Report POS 10 (patient in home) or POS 02 (patient in facility). Append CPT Modifier 95 for synchronous audio-video or Modifier 93 where audio-only is permitted. |
| 99202–99215 | Outpatient Evaluation and Management (E/M) visits for psychiatric medication management billed by medical decision making (MDM) or total time. | Commonly billed as 99213 or 99214 for follow-up psychopharmacology visits; pair with POS 10/02 and Modifier 95. |
| 90833 / 90836 / 90838 | Add-on psychotherapy codes (16–37 min, 38–52 min, or 53+ min) billed only in conjunction with an E/M code by a prescribing psychiatrist or PMHNP. | Requires distinct documentation of both the E/M medical decision making and the time-based psychotherapy modality; append Modifier 95. |
| 90832 / 90834 / 90837 | Standalone individual psychotherapy (30, 45, or 60 minutes) without medical evaluation and management services. | Eligible for both synchronous audio-video (Modifier 95) and CMS permanent behavioral health audio-only telehealth pathways (Modifier 93 / FQ when clinical criteria are met). |
| 99492 / 99493 / 99494 | Psychiatric Collaborative Care Management (CoCM): initial month (70 min), subsequent month (60 min), and each additional 30 minutes. | Billed monthly by the primary care or treating billing practitioner covering care manager outreach and remote psychiatric consultant registry review. |
Frequently Asked Questions
What is telepsychiatry?
Telepsychiatry is the delivery of psychiatric assessments, medication management, psychotherapy, and crisis or collaborative care consultations via telecommunications technology—primarily HIPAA-compliant, real-time audio-video conferencing. It enables psychiatrists and psychiatric nurse practitioners to evaluate and treat patients remotely in their homes, primary care clinics, or hospital emergency departments.
Can a telepsychiatrist prescribe controlled substances like ADHD stimulants or buprenorphine?
Yes, subject to federal DEA and state regulations. Under the DEA and HHS Third Temporary Extension of COVID-19 Telemedicine Flexibilities (effective through December 31, 2026), DEA-registered practitioners may prescribe Schedule II–V controlled substances—including ADHD stimulants and buprenorphine for opioid use disorder—via synchronous audio-video telepsychiatry without a prior in-person evaluation, provided they comply with state licensure, state PDMP checks, and EPCS requirements.
What features are required in a clinical telepsychiatry platform?
A clinical telepsychiatry platform requires a signed HIPAA Business Associate Agreement (BAA), end-to-end encrypted WebRTC video, EPCS-enabled e-prescribing with integrated state PDMP lookup, automated pre-visit behavioral health screening (PHQ-9, GAD-7, C-SSRS), physical location verification at check-in, and segregated storage for HIPAA psychotherapy notes and 42 CFR Part 2 records.
